During a secondary Listeria monocytogenes infection in mice, the bacteria are eliminated more rapidly from the liver and spleen than during a primary infection. This acquired resistance against a secondary infection is dependent on T lymphocytes, which induce enhanced elimination of bacteria via stimulation of effector cells such as neutrophils, resident macrophages, exudate macrophages, and hepatocytes. The aim of the present study was to determine the role of the resident macrophages in acquired resistance against a secondary L. monocytogenes infection in mice. Mice which had recovered from a sublethal primary infection with 0. Mice that survive a primary Listeria monocytogenes infection, i.e., immune mice, are able to eliminate the bacteria much faster and more efficiently from their organs during a secondary infection than nonimmune mice with a primary infection (21). This acquired resistance against infection is mediated by two groups of cells: inducers of acquired resistance and effectors of acquired resistance. Mackeness identified T lymphocytes as the major inducers of acquired resistance by the observation that adoptive transfer of spleen cells from Listeriaimmune mice to naive mice protected the latter against a L. monocytogenes infection (22). CD8 ϩ T lymphocytes were found to be the most effective inducers of acquired resistance, whereas CD4 ϩ T lymphocytes were thought to be involved in the delayed-type hypersensitivity reaction and granuloma formation (14, 23). However, recent studies with major histocompatibility complex type I (MHCI) and MHCII knockout mice, which are devoid of functional CD4 ϩ and CD8 ϩ ␣␤ T lymphocytes, respectively, revealed that both T-lymphocyte subsets are necessary for the induction of acquired resistance against a secondary L. monocytogenes infection (18).
Mice that survive a primary Listeria monocytogenes infection, i.e., immune mice, are able to eliminate the bacteria much faster and more efficiently from their organs during a secondary infection than nonimmune mice with a primary infection (21) . This acquired resistance against infection is mediated by two groups of cells: inducers of acquired resistance and effectors of acquired resistance. Mackeness identified T lymphocytes as the major inducers of acquired resistance by the observation that adoptive transfer of spleen cells from Listeriaimmune mice to naive mice protected the latter against a L. monocytogenes infection (22) . CD8 ϩ T lymphocytes were found to be the most effective inducers of acquired resistance, whereas CD4 ϩ T lymphocytes were thought to be involved in the delayed-type hypersensitivity reaction and granuloma formation (14, 23) . However, recent studies with major histocompatibility complex type I (MHCI) and MHCII knockout mice, which are devoid of functional CD4
ϩ and CD8 ϩ ␣␤ T lymphocytes, respectively, revealed that both T-lymphocyte subsets are necessary for the induction of acquired resistance against a secondary L. monocytogenes infection (18) .
Efficient elimination of bacteria from the organs during a secondary infection is dependent on effector cells. Irradiation of naive mice before an adoptive transfer of spleen cells from Listeria-immune mice abrogated the protection against a L. monocytogenes infection, demonstrating that bone marrow-derived effector cells are necessary for the expression of acquired resistance (13) . Treatment of naive mice with dextran sulfate 500, a compound which affects the phagocytic capacity of mononuclear phagocytes, also inhibited the expression of acquired resistance against infection after adoptive transfer, confirming that the bone marrow-derived effector cells are the mononuclear phagocytes (12) . Recently, it has been demonstrated that neutrophils can be selectively depleted with a monoclonal antibody and that these cells are also required for the elimination of bacteria during a secondary L. monocytogenes infection (5, 6, 29) . Since irradiation and dextran sulfate affect various cell types, the role of mononuclear phagocytes, in particular the resident macrophages and the exudate macrophages, in the elimination of bacteria during a secondary infection in mice should be reevaluated. Recently, a method has been described which allows selective depletion of resident macrophages without affecting monocytes or granulocytes (39) . The aim of the present study is to determine the role of the resident macrophages in acquired resistance against a secondary L. monocytogenes infection in mice.
MATERIALS AND METHODS
Mice. Female, specific-pathogen-free CBA/J mice, aged 6 to 8 weeks, were purchased from IFFA Credo (Saint Germaine-sur-l'Abersle, France) and given dry food (Hope Farms, Woerden, The Netherlands) and tap water ad libitum.
Bacteria. L. monocytogenes EGD was kept virulent by repeated passage through CBA/J mice and stored on blood agar plates at 4ЊC. The bacteria were cultured in tryptose phosphate broth for 18 h at 37ЊC, collected by centrifugation (10 min at 900 ϫ g), washed in phosphate-buffered saline (pH 7.4) (PBS), and resuspended in pyrogen-free saline.
For several experiments the bacteria were preopsonized by incubation of 2 ϫ 10 7 bacteria/ml with 20% (vol/vol) normal mouse serum for 30 min at 37ЊC under rotation (4 rpm) followed by centrifugation (10 min at 900 ϫ g). After washing twice with Hanks' balanced salt solution supplemented with 0.1% gelatin and 10 mM HEPES (gelatin-HBSS), the bacteria were resuspended in gelatin-HBSS to a concentration of 10 7 /ml. Monoclonal antibodies. The following monoclonal antibodies (MAb) were used: MOMA-1, a rat immunoglobulin G2a (IgG2a) antibody that recognizes the marginal metallophilic macrophages in the mouse spleen (16); MOMA-2, a rat IgG2b antibody used as a pan-macrophage marker (17) ; ERTR-9, a rat IgM antibody that recognizes the splenic marginal-zone macrophages (41) ; and M1/ 70, a rat IgG2b anti-CR3 ␣ chain (CD11b, MAC-1 ␣ chain) which recognizes monocyte-derived exudate macrophages (34) . For immunohistochemistry, the MAb were used in the form of tissue culture supernatants.
Liposome preparation. Multilamellar liposomes containing either dichloromethylene diphosphonate (Cl 2 MDP; a gift from Boehringer Mannheim GmbH, Mannheim, Germany) or PBS were prepared as previously described (39) . Briefly, 75 mg of phosphatidylcholine (Lipoid GmbH, Ludwigshafen, Germany) and 11 mg of cholesterol (Sigma Chemical Co., St. Louis, Mo.) were dissolved in chloroform, evaporated by rotation under vacuum at 37ЊC, dispersed by mixing with 10 ml of PBS containing 2.5 g of Cl 2 MDP for 10 min, placed at room temperature (RT) for 2 h, sonicated for 3 min at RT in a water bath sonicator, and placed at RT for 2 h. The resulting liposomes containing Cl 2 MDP (LCl 2 MDP) were washed twice in PBS by centrifugation at 100,000 ϫ g for 30 min to remove nonencapsulated Cl 2 MDP. PBS-containing liposomes (L-PBS) were prepared by the same procedure, except that the phosphatidylcholine-cholesterol mixture was dispersed in 10 ml of PBS without CL 2 MDP. The L-Cl 2 MDP and L-PBS were each suspended in 4 ml of PBS, and 0.2 ml of either preparation was injected intravenously (i.v.) per mouse. On day 3 of primary or secondary infection, blood samples were taken from the mice by heart puncture, collected in a heparinized tube, and stored as plasma at Ϫ20ЊC until use. The liver and spleen were removed and homogenized with a tissue homogenizer (type X-1020; Ystral GmbH, Döttingen, Germany). Serial 10-fold dilutions of the organ suspensions were plated onto blood-agar plates and incubated for 24 h at 37ЊC. The number of colonies was used to calculate the number of viable L. monocytogenes cells per organ.
Induction of primary or secondary L. monocytogenes infection in mice.
Analysis of blood leukocytes and PEC. Immune mice were given 0.2 ml of L-Cl 2 MDP, L-PBS, or PBS i.v., and after 2 days blood samples were taken by puncture of the retroorbital plexus and collected in a heparinized tube. Total blood leukocytes were counted with a Coulter Counter (model ZF; Coulter Electronics Ltd., Luton, England). The percentages of blood granulocytes, monocytes, and lymphocytes were determined by differential counting of blood smears stained with Giemsa and May-Grünwald. To obtain peritoneal exudate cells (PEC), immune mice were first treated with L-Cl 2 MDP, L-PBS, or PBS i.v. and after 2 days given an i.p. injection of 5 ϫ 10 7 heat-killed (70ЊC for 60 min) L. monocytogenes cells. Two days later, PEC were collected by peritoneal lavage with 2 ml of ice-cold PBS containing 50 U of heparin per ml, as previously described (37) . The composition of the cell suspension was determined by analysis of Giemsa-stained cytospin preparations. The remaining cells were used for in vitro phagocytosis and killing of L. monocytogenes.
In vitro phagocytosis and killing of L. monocytogenes by inflammatory leukocytes. In vitro phagocytosis and killing were performed as previously described (19) . In short, a suspension containing 10 7 PEC/ml and 10 7 preopsonized bacteria/ml was incubated for 15 min at 37ЊC under rotation (4 rpm). After phagocytosis, the PEC were centrifuged at 240 ϫ g for 4 min at 4ЊC and washed three times with ice-cold gelatin-HBSS to remove bacteria that were not cell associated. The PEC were resuspended at the original concentration in gelatin-HBSS containing 10% (vol/vol) normal mouse serum. Cytospin preparations with 10 4 PEC were made to determine the percentage of cells with cell-associated bacteria. The remaining PEC were divided into three aliquots that were incubated for 0, 30, and 60 min at 37ЊC under rotation (4 rpm). After incubation, the PEC were lysed by addition of H 2 O containing 0.01% (vol/vol) bovine serum albumin (BSA) under vigorous mixing for 1 min. Serial 10-fold dilutions were plated onto blood-agar plates, and the number of viable bacteria, i.e., intracellular and cell-associated bacteria, was determined microbiologically. The intracellular killing was reflected by a decrease in the percentage of bacteria at 30 and 60 min relative to the beginning of the assay at 0 min. At the end of the assay, the viability of the PEC as indicated by trypan blue exclusion exceeded 95%.
Measurement of RNI. The concentration of nitrite (NO 2 Ϫ ) and nitrate (NO 3 Ϫ ), which are stable metabolites of nitric oxide (NO), was measured in plasma of infected mice. A plasma sample was diluted twofold with deionized H 2 O and deproteinized with 30% zinc sulfate; NO 3 Ϫ in the sample was reduced to NO 2 Ϫ by incubation with spongy cadmium (11); the concentration of NO 2 Ϫ was determined with Griess reagent (25) and referred to as reactive nitrogen intermediates (RNI). 
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Measurement of liver enzymes. The concentrations of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum were measured by using routine clinical laboratory procedures.
Immunohistochemistry. On day 3 of primary or secondary infection, segments of the liver and spleen (one segment per organ) were immediately removed, rapidly frozen in liquid nitrogen, and stored at Ϫ70ЊC until use. Cryostat sections of the spleen and liver were made at a thickness of 8 m at Ϫ20ЊC, fixed in acetone for 10 min, and air dried. Acid phosphatase staining, which specifically stains resident macrophages in the mouse liver and spleen (40), was performed by the method of Burstone (2) for 20 min at 37ЊC. As indicated, several sections were incubated with 4-chloro-1-naphtol (Sigma Chemical Co.) in Tris-HCl buffer (pH 7.6) supplemented with 0.01% H 2 O 2 to visualize endogenous peroxidase activity prior to immunoperoxidase staining. For the immunoperoxidase staining, the fixed sections were incubated for 60 min at RT with either MOMA-1, MOMA-2, ERTR-9, or M1/70 diluted in PBS containing 0.1% (vol/vol) BSA (PBS-BSA). Control sections were incubated with PBS-BSA. After incubation, the sections were washed thoroughly in PBS and incubated for 30 min at RT with peroxidase-labeled rabbit anti-rat Ig diluted 1/300 in PBS-BSA-1% normal mouse serum. The sections were washed, and peroxidase activity was visualized by incubation with either 0. Statistical analysis. Results are expressed as the mean Ϯ standard deviation (SD) for at least eight mice per time point, unless otherwise indicated. Differences among various groups were assessed by means of a one-way analysis of variance followed by a Fisher's least-significant-difference comparison report. For all analyses, the level of significance was set at 0.05. When a mouse died during the experiment, the numbers of bacteria in the liver and spleen could not be determined and were excluded from subsequent analyses.
RESULTS

Number of L. monocytogenes cells in liver and spleen and concentration of RNI in plasma of L-Cl 2 MDP-treated immune mice with a secondary infection.
On day 3 of a secondary infection, the number of L. monocytogenes in the livers of immune mice treated with L-Cl 2 MDP was significantly larger (mean difference, log 10 5.03 Ϯ 1.25) than that of PBS-or L-PBS-treated immune mice and was also larger (mean difference, log 10 3.69 Ϯ 1.36) than that of nonimmune mice with a primary infection (Fig. 1A) . The number of bacteria recovered from the spleens of immune mice treated with L-Cl 2 MDP was significantly increased (mean difference, log 10 4.23 Ϯ 1.14) in comparison with that of PBS-or L-PBS-treated immune mice on day 3 of secondary infection and was slightly (mean difference, log 10 1.32 Ϯ 0.32) larger than that of nonimmune mice with a primary infection (Fig. 1B) . On day 3 of a secondary infection, two of eight L-Cl 2 MDP-treated immune mice had died and the remaining six mice were cachectic, characterized by extensive weight loss, decreased body temperature, and immobility. All PBS-and L-PBS-treated immune mice and mice with a primary infection survived and were otherwise healthy.
Since we have demonstrated that the concentration of RNI in plasma can be considered a parameter for the severity of infection (33) , the concentration of RNI in plasma was determined in PBS-, L-PBS-, and L-Cl 2 MDP-treated immune mice with a secondary infection and in mice with a primary infection. On day 3 of infection, the concentration of RNI in the plasma of immune mice treated with L-Cl 2 MDP was 70-fold higher than that in the plasma of immune mice treated with PBS or L-PBS and of nonimmune mice with a primary infection (Fig. 1C) .
Peripheral blood leukocytes in L-Cl 2 MDP-treated immune mice. To confirm that L-Cl 2 MDP treatment did not affect the number of peripheral blood leukocytes in immune mice, total blood leukocyte counts and differential counts were performed before a secondary infection with L. monocytogenes. Two days after L-Cl 2 MDP treatment, the total number of leukocytes in the blood of L-Cl 2 MDP-treated immune mice was not different from that in the blood of L-PBS-treated immune mice and nonimmune mice but was slightly larger (P Ͻ 0.05) than that in the blood of PBS-treated immune mice (Table 1) . This increase in the number of blood leukocytes due to i.v. injection of liposomes has also been described by others (28, 31) .
The percentages of monocytes, lymphocytes, and granulocytes in the blood of L-Cl 2 MDP-treated immune mice were comparable to those in the blood of nonimmune and PBStreated immune mice (P Ͼ 0.05) ( Table 1) . Treatment with L-PBS induced a slight increase (P Ͻ 0.05) in the percentage of blood monocytes in immune mice (Table 1) .
Migration and functional activity of peritoneal exudate cells from L-Cl 2 MDP-treated immune mice. To ensure that L-Cl 2 MDP does not affect the migration of leukocytes from the blood to the site of inflammation, the migration of leukocytes to the peritoneal cavity in response to an intraperitoneal stimulus was studied. Two days after injection of heat-killed L. monocytogenes into the peritoneal cavity, the total number of PEC from L-Cl 2 MDP-treated immune mice did not significantly differ from the total number of PEC from nonimmune and PBS-and L-PBS-treated immune mice ( Table 2 ). The percentages of macrophages and granulocytes recovered from the peritoneal cavity of immune mice were higher than those from nonimmune mice ( Table 2) , but within the groups of immune mice, the percentages of macrophages, lymphocytes, and granulocytes were similar (Table 2) .
To determine whether i.v. treatment with L-Cl 2 MDP affected the functional activity of migrating leukocytes, the phagocytosis and killing of L. monocytogenes by the PEC was investigated. After in vitro phagocytosis of live L. monocytogenes for 15 min, the percentage of PEC with cell-associated bacteria did not differ from that in PBS-, L-PBS-, and L-Cl 2 MDP-treated immune mice (P Ͼ 0.05) ( Table 3) . Treatment with L-Cl 2 MDP i.v. did not alter the killing of L. monocytogenes by PEC from the immune mice (P Ͼ 0.05) ( Table 3) . Histology. In the spleens of immune mice treated with L-Cl 2 MDP, almost no acid phosphatase-positive cells, i.e., resident macrophages, could be detected on day 3 of a secondary infection except for a few positive cells in the white pulp (Fig.  2b) . In the spleens of PBS-treated immune mice, acid phosphatase-positive cells were abundant on day 3 of a secondary infection (Fig. 2a) . No marginal-zone macrophages (Fig. 2d) or marginal metallophilic macrophages (data not shown) could be detected in the spleens of L-Cl 2 MDP-treated mice with the MAb ERTR-9 (41) and MOMA-1 (16), respectively, whereas many positive cells were present in the spleens of PBS-treated immune mice (Fig. 2c) . In the livers of L-Cl 2 MDP-treated immune mice, no acid phosphatase-positive Kupffer cells could be found on day 3 of a secondary infection, whereas in the livers of PBS-treated immune mice, positively staining Kupffer cells were abundant (data not shown).
Effect of L-Cl
Immunoperoxidase staining with MAb M1/70 (34) on day 3 of a secondary infection showed many exudate macrophages in inflammatory foci in the livers (Fig. 2e and f) and spleens (data not shown) of PBS-and L-Cl 2 MDP-treated immune mice. The number of inflammatory foci per square millimeter of liver section was significantly increased in L-Cl 2 MDP-treated immune mice in comparison to PBS-and L-PBS-treated immune mice with a secondary infection (Fig. 3) . In PBS-treated immune mice, the inflammatory foci were large and consisted of a center with densely packed exudate macrophages surrounded by a layer of necrotic cells, granulocytes, and exudate macrophages (Fig. 2e) . In L-Cl 2 MDP-treated immune mice, the inflammatory foci were small, did not have a well-defined structure, and consisted mainly of exudate macrophages (Fig. 2f) . The granulocytes in the livers (Fig. 2e ) and spleens (data not shown) of PBS-treated immune mice were confined to wellstructured inflammatory foci, whereas the granulocytes in L-Cl 2 MDP-treated immune mice were scattered throughout the liver (Fig. 2f) . The number of inflammatory foci in the livers of L-PBS-treated immune mice was similar to that in PBS-treated immune mice but approximately twofold lower than that in mice with a primary infection. These results confirm that the immune mice possess acquired resistance against a secondary infection (20) .
Number of L. monocytogenes cells in the livers and spleens and concentration of RNI in plasma of Cl 2 MDP-treated immune mice given an injection of TNF during a secondary infection. Since TNF is essential for acquired resistance against a secondary infection (32) and activated macrophages secrete TNF, the effect of administration of TNF to L-Cl 2 MDPtreated immune mice that are devoid of resident macrophages was assessed. Intravenous injection of TNF 1 h prior to a secondary infection tended to decrease the number of L. monocytogenes cells in the livers (P Ͼ 0.05) and spleens (P Ͼ 0.05) and the number of inflammatory foci in the livers of L-Cl 2 MDP-treated immune mice (2.41 Ϯ 0.25) (P Ͼ 0.05) in comparison with L-Cl 2 MDP-treated immune mice that received saline (2.73 Ϯ 0.49). However, the concentration of RNI in plasma was significantly decreased (P Ͻ 0.05) in these b The percentage of PEC with cell-associated bacteria was assessed microscopically.
c After incubation for 0, 30, and 60 min at 37ЊC under rotation, the cells were lysed and the number of live bacteria, i.e., viable intracellular and cell-associated bacteria, was assessed. The killing was reflected as the decrease in the percentage of bacteria at 30 and 60 min relative to that at 0 min. L-Cl 2 MDP-treated immune mice (Fig. 4) . Injection of TNF 24 h after challenge did not affect the number of bacteria in the livers and spleens or the concentration of RNI in the plasma of L-Cl 2 MDP-treated immune mice (Fig. 4) .
DISCUSSION
From the above results, it can be concluded that resident macrophages are required for the expression of acquired resistance during a secondary L. monocytogenes infection in immune mice. This conclusion is supported by the observation that during a secondary infection in mice depleted of resident macrophages, the number of L. monocytogenes cells in the livers and spleens was significantly higher than that in control mice. Furthermore, the concentration of RNI in the plasma of these mice, which is considered a measure for the severity of Listeria infection (33) , was dramatically increased in comparison with control mice. In addition, in the livers and spleens of these mice the inflammatory foci increased in number and drastically decreased in size in comparison with control mice.
In this study, i.v. treatment with liposome-encapsulated Cl 2 MDP was used to selectively deplete resident macrophages from the livers and spleens of immune mice. The efficacy of the method was assessed by histological evaluation of the livers and spleens, which confirmed that all resident macrophages were eliminated except for a few positively stained macrophages in the white pulp of the spleen, as has been found previously (28, 31, 39) . Treatment with L-Cl 2 MDP was not hepatotoxic and did not affect the number of monocytes, lymphocytes, and granulocytes in the circulation. The migration of these cells to the peritoneal cavity during a peritonitis induced by heat-killed L. monocytogenes was slightly but not significantly affected by L-Cl 2 MDP-treatment, as reported by others (28) . Additional evidence that leukocytes migrate normally to the sites of inflammation in L-Cl 2 MDP-treated immune mice is provided by the abundance of exudate macrophages and granulocytes in the livers and spleens of these mice during a secondary L. monocytogenes infection. Intravenous treatment of mice with L-Cl 2 MDP, which does not reach the peritoneal cavity, did not affect the endocytic activity of PEC (75% macrophages and 13% granulocytes) to phagocytose and kill L. monocytogenes in vitro. What roles do resident macrophages play during an L. monocytogenes infection? During a primary L. monocytogenes infection, Kupffer cells lining the sinusoids (26) in the liver rapidly take up the bacteria from the circulation (3). The majority of ingested bacteria will be killed by the Kupffer cells, but a small proportion of bacteria escapes from these macrophages and invades adjacent hepatocytes in which it will replicate (3, 10) . During the next phase of a primary infection, granulocytes and monocyte-derived exudate macrophages migrate to the liver and form inflammatory foci, where the bacteria are eliminated (4, 26, 30) . Depletion of resident macrophages from naive mice before a primary L. monocytogenes infection drastically increases the mortality rate, which demonstrates that resident macrophages are required for resistance against a primary infection (27) .
During a secondary infection, the sequence of events is probably very similar to that during a primary infection. During a secondary infection, Kupffer cells also phagocytose and kill L. monocytogenes (10) , but the bacteria do not replicate in activated hepatocytes and are even eliminated by these cells (10, 15, 35) . In the present study, when resident macrophages were absent during a secondary infection, many more bacteria spread throughout the liver during the first phase of infection, leading to numerous inflammatory foci, consisting of granulocytes and exudate macrophages, scattered through the liver as observed in L-Cl 2 MDP-treated immune mice on day 3 of infection.
Despite the presence of granulocytes and monocyte-derived exudate macrophages in the livers and spleens of macrophagedepleted immune mice, the bacteria were not eliminated and even increased in number. Are the phagocytes in these organs impaired in their function? It is unlikely that L-Cl 2 MDP taken up by resident macrophages is released as free Cl 2 MDP upon the death of these cells and affects the function of granulocytes and exudate macrophages in the liver and spleen. Since resident macrophages are eliminated 24 h after i.v. L-Cl 2 MDP treatment and free Cl 2 MDP has a half-life in the tissues of a few minutes (8, 39) , it is very improbable that 48 h after injection of L-Cl 2 MDP, when the secondary infection is induced, free Cl 2 MDP is present in the liver and spleen. In addition, free Cl 2 MDP does not easily cross cell membranes and is not endocytosed by cells (8, 39) . Other cells that contribute to a secondary L. monocytogenes infection such as T lymphocytes, dendritic cells, and endothelial cells were shown not to be affected by L-Cl 2 MDP-treatment (1, 31, 38) .
Another important characteristic of resident macrophages, which are activated during a secondary infection in immune mice, is their ability to produce and secrete cytokines which are required for optimal stimulation of granulocytes, exudate macrophages, and hepatocytes (9, 10) . In the livers of immune mice infected with L. monocytogenes, TNF, interleukin-1␤, and interleukin-6 mRNAs are detected as early as 30 min after infection (7) and high concentrations of TNF are present in the serum of immune mice during the first 24 h of a secondary infection (24) . In addition, we have demonstrated that neutralization of TNF during a secondary infection dramatically increases the number of L. monocytogenes cells in the liver and spleen (32) . Since the course of a secondary infection in the livers and spleens of anti-TNF-treated immune mice is similar to that in L-Cl 2 MDP-treated immune mice, we supposed that administration of TNF to L-Cl 2 MDP-treated immune mice could restore their resistance against an infection. Our findings demonstrate that although treatment with TNF prior to a secondary infection only slightly decreased the number of bacteria in the liver and spleen and the number of inflammatory foci in the liver, it significantly reduced the concentration of RNI in plasma from immune mice depleted of resident macrophages. The latter observation indicates that treatment with TNF somewhat attenuates the Listeria infection in macrophage-depleted immune mice. Whether higher concentrations of TNF, longer treatment with this cytokine, or treatment with a mixture of cytokines can substitute for the paracrine function of resident macrophages has not yet been elucidated.
In sum, our findings demonstrate that besides neutrophils and exudate macrophages, resident macrophages are required for the expression of acquired resistance against a secondary L. monocytogenes infection in mice.
